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CathepsinKCre mediated deletion 
of βcatenin results in dramatic loss 
of bone mass by targeting both 
osteoclasts and osteoblastic cells
Paula Ruiz1, Marta Martin-Millan1,2, M. C. Gonzalez-Martin3, Maria Almeida4,  
Jesús González-Macias1,2,5,6 & Maria A. Ros3,7
It is well established that activation of Wnt/βcatenin signaling in the osteoblast lineage leads to 
an increase in bone mass through a dual mechanism: increased osteoblastogenesis and decreased 
osteoclastogenesis. However, the effect of this pathway on the osteoclast lineage has been less 
explored. Here, we aimed to examine the effects of Wnt/βcatenin signaling in mature osteoclasts by 
generating mice lacking βcatenin in CathepsinK-expressing cells (Ctnnb1f/f;CtsKCre mice). These mice 
developed a severe low-bone-mass phenotype with onset in the second month and in correlation 
with an excessive number of osteoclasts, detected by TRAP staining and histomorphometric 
quantification. We found that WNT3A, through the canonical pathway, promoted osteoclast apoptosis 
and therefore attenuated the number of M-CSF and RANKL-derived osteoclasts in vitro. This reveals 
a cell-autonomous effect of Wnt/βcatenin signaling in controlling the life span of mature osteoclasts. 
Furthermore, bone Opg expression in Ctnnb1f/f;CtsKCre mice was dramatically decreased pointing to 
an additional external activation of osteoclasts. Accordingly, expression of CathepsinK was detected in 
TRAP-negative cells of the inner periosteal layer also expressing Col1. Our results indicate that the bone 
phenotype of Ctnnb1f/f;CtsKCre animals combines a cell-autonomous effect in the mature osteoclast 
with indirect effects due to the additional targeting of osteoblastic cells.
Evidence accumulated during the last few years has established that the Wnt/β catenin pathway is critical for bone 
formation and skeletal homeostasis1,2. The initial evidence came from the identification of loss-of-function (LOF) 
and gain-of-function (GOF) mutations in the human LRP5 gene (low-density-lipoprotein receptor-related pro-
tein 5; a co-receptor of the Wnt/β catenin pathway) as responsible for the Osteoporosis-Pseudoglioma Syndrome 
and for the hereditary High Bone Mass trait, respectively3,4. The bone phenotypes of these mutations were later 
reproduced in genetically modified mouse models of Lrp5 function, further highlighting the anabolic role of Wnt/
β catenin signaling in bone5.
Genetic studies in mice manipulating βcatenin, the obligatory component of canonical Wnt signaling, have 
established that β catenin in the osteoblast lineage increases bone mass through different mechanisms, depend-
ing on the specific differentiation stage of the cell6–11. For instance, activation of canonical Wnt signaling by 
stabilization of β catenin in mesenchymal progenitor cells, plays an essential role in controlling osteoblast versus 
chondrocyte differentiation and in promoting osteoblast proliferation and differentiation6,7,9. Moreover, Wnt/β 
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catenin signaling in osteoblast and osteocytes upregulates the osteoclasts inhibitor factor osteoprotegerin (OPG) 
and thereby inhibits osteoclast formation and bone resorption10,11. Bone loss mediated by decreasing OPG expres-
sion is also observed in the conditional deletion of βcatenin in type II Collagen expressing cells12. Thus, a cell- 
autonomous mechanism promoting proliferation and maturation of osteoblasts together with an indirect non 
cell-autonomous mechanism, mediated by an OPG-dependent reduction in osteoclast numbers, contribute to 
the high bone mass phenotype.
The involvement of osteoclasts as mediators of some of the effects of Wnt/β catenin signaling in the osteoblast 
lineage, the ubiquity of WNT proteins and the expression of components of the Wnt canonical pathway in the 
osteoclast lineage raised the question of whether this pathway could also play a cell-autonomous role in the oste-
oclast biology13,14. To explore this possibility, several attempts have been made to genetically manipulate βcatenin 
in the osteoclast lineage15–18. For example, the LysozimeMCre (LysMCre) deleter line, which drives recombination 
specifically in monocyte/macrophages and neutrophils19 has been used to perform gain17 and loss15–17 of func-
tion of βcatenin in osteoclast precursors. βcatenin deletion in LysozimeM expressing cells leads to osteopenia by 
increasing osteoclastogenesis but without altering OPG levels. These results suggest that direct actions of Wnt/
β catenin signaling in the osteoclast lineage contribute to bone homeostasis15–17. However, in these models the 
genetic manipulation of βcatenin is not restricted to the osteoclasts but it also affects other cell types such as mac-
rophages and neutrophils which could potentially contribute to the phenotype. In the present work, we aimed 
to study the function of Wnt/β catenin specifically in mature osteoclasts using the CtsKCre deleter line, which is 
commonly used to target osteoclasts at their late stage of differentiation20–22. CtskCre;βcatenin mice developed 
severe low-bone-mass caused by excessive osteoclast numbers. In vitro experiments showed that Wnt signaling 
decreased osteoclast numbers by reducing their life span in a cell-autonomous manner. We also identified a pop-
ulation of osteogenic cells located in the inner layer of the periosteum that express Ctsk postnataly. The CtskCre 
mediated removal of βcatenin in this population of osteoblasts, most probably, led to reduction in OPG produc-
tion, thereby, contributing to the excessive osteoclast formation and dramatic loss of bone mass.
Results
Generation of mice with specific βcatenin deletion in Ctsk-expressing cells. Conditional inactiva-
tion of βcatenin (MGI: Ctnnb1) in mature osteoclasts was performed using the βcatenin floxed allele (Ctnnb1f;23) 
and the CathepsinK;Cre line (CtsKCre;21) that harbors the Cre recombinase at the CathepsinK locus. We generated 
two cohorts (males and females) of mice lacking βcatenin in CtsK-expressing cells, hereafter referred to as Ctnnb1f/
f;CtsKCre or experimental mice (n = 13 males and 17 females), and they were compared with the corresponding 
Ctnnb1f/f littermate animals, considered as controls (n = 21 males and 20 females). Ctnnb1f/f;CtsKCre mice were born 
at the expected Mendelian ratio and their gross external aspect and size were indistinguishable from control mice. 
However, during the second month of postnatal life, the experimental Ctnnb1f/f;CtsKCre mice became clearly distinct 
from their control littermates due to an abnormal gait, malposition of the hindlimbs and sparse fur appearance as 
shown for 12-weeks old animals in Fig. 1b. Differences in body weight were also seen in males at this age (Fig. 1a). 
All experimental animals died between 14 and 15 weeks of age, a time when animals appeared sick.
Excision of the βcatenin gene was assessed by qRT-PCR in ex vivo cultures of bone marrow (BM)-derived 
macrophages and osteoclasts obtained from the femur of experimental and control 4–6 week-old mice. βcatenin 
mRNA levels in macrophages from Ctnnb1f/f;CtsKCre mice were indistinguishable from controls while in osteo-
clasts βcatenin levels were reduced by approximately 60% (Fig. 1c). The magnitude of the reduction in βcatenin 
was similar to the one seen with other Cre-deleter models10,11. The remaining βcatenin seen in cultures from 
experimental mice was, most probably, due to the presence of non-CtsK-expressing cells, of the hematopoietic or 
mesenchymal lineages.
βcatenin deletion in CtsK-expressing cells causes a severe loss of bone mass. The hindlimb mal-
position and abnormal gait of Ctnnb1f/f;CtsKCre mice pointed to a skeletal phenotype. To start characterizing 
this phenotype we performed a sequential X-ray examination of the hindlimbs and spine of both experimental 
and control animals. As early as 6 weeks of age, experimental animals exhibited cortical thinning and alterations 
in shape including widening of the distal third of the femur and proximal third of the tibia (Fig. 2a, left panels). 
Furthermore, the secondary ossification center in the distal femur and proximal tibia were markedly misshapen 
in experimental animals. Poor mineralization of the vertebral bodies was also evident at 12 weeks of age (Fig. 2a, 
right panels). In line with the X-ray analysis, monthly DEXA bone mineral density BMD analysis showed a reduc-
tion of bone mass in the spine of Ctnnb1f/f;CtsKCre females, in the second analysis performed at 8 weeks and in 
both the spine and femur of females and males at 12 weeks (Fig. 2b).
To examine the bone microarchitecture in Ctnnb1f/f;CtsKCre mice, we performed micro-computed tomography 
(μ CT) of the femur and fifth lumbar vertebra (L5) of 6 and 12 week-old animals. The μ CT images showed a clear 
bone loss in the distal femur in 6 week-old animals (Fig. 3a). Compared with respective controls, experimental 
female and male mice had decreased trabecular number (TbN) and increased trabecular separation (TbSp) (Fig. 3b). 
However, the bone volume fraction (BV/TV) was not significantly different from controls (Fig. 3b). At 12 weeks of 
age, μ CT scans of the distal femur revealed a dramatic loss of both cortical and trabecular bone (Fig. 3c) and both 
female and male experimental animals showed 50% decrease in BV/TV (Fig. 3d). However, no significant changes 
were detected in trabecular number and spacing but trabecular thickness was significantly increased in females 
(Fig. 3d). Moreover, despite the enormous damage seen in cortical bone at the distal end, the average cortical thick-
ness (Th.) at the midshaft was unaffected in both male and female Ctnnb1f/f;CtsKCre mice (Fig. 3d).
Like in the femur, cortical and trabecular bone were dramatically reduced in vertebra (L5) of 12-week-old 
experimental mice (Fig. 3e). Specifically, female and male mice exhibited a decrease in BV/TV, trabecular num-
ber, and an increase in trabecular spacing (Fig. 3f). Trabecular thickness was significantly higher in the experi-
mental females (Fig. 3f).
www.nature.com/scientificreports/
3Scientific RepoRts | 6:36201 | DOI: 10.1038/srep36201
Together, these results indicate that βcatenin deletion in CtsK-expressing cells causes a severe loss of both 
cortical and trabecular bone that started after the first month of postnatal life and worsen progressively.
Ctnnb1f/f;CtsKCre mice exhibit normal bone development up to 4 weeks of age. A sequential 
Hematoxylin-eosin examination of femur and vertebra sections was performed to further investigate the onset 
of the phenotype and the bone structure of experimental animals. Up to 4 weeks of postnatal development, both 
femur and vertebra appeared normal in experimental animals (Fig. 4a,c). However, a dramatic reduction in both 
the trabecular and cortical bone compartments was evident by 12 weeks old Ctnnb1f/f;CtsKCre mice (Fig. 4a–c) 
with cortical bone absent from wider areas of the distal femur (arrows in Fig. 4a) and vertebra (arrowheads in 
Fig. 4c) in 12 weeks old experimental animals. The loss of bone in distal femur was obvious in the fresh bone 
(Fig. 4b) and accompanied by extensive bone marrow adiposity (Fig. 4d). It should be noted, that the long bone 
phenotype was not restricted to the distal femur, as similar findings were observed in the proximal tibia (not 
shown) and humerus (Fig. 4e).
The results of the histological analysis confirm that Wnt/β catenin signaling in CtsK-expressing cells is not 
necessary for normal skeletogenesis up to the end of the first month of postnatal life and suggest that excess 
bone destruction, starting between 4 and 6 weeks, might be the primary mechanism involved in the bone loss 
phenotype.
Figure 1. External appearance of Ctnnb1f/f;CtsKCre mice and βcatenin expression in macrophages and 
osteoclasts. (a) Comparison of body weight between control and experimental littermate mice at 8 and 12 
weeks of postnatal life (g, grams). (b) External body appearance of 12-week-old control and experimental 
mice. (c) RT-PCR quantification of βcatenin transcripts in macrophages and osteoclasts developed from non-
adherent bone marrow cells cultured in the presence of M-CSF for 4 days, and M-CSF plus RANKL for 5 days, 
respectively (n = 4). Bars, Mean ± SD; *P < 0.05.
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Ctnnb1f/f;CtsKCre mice exhibit increased osteoclast numbers. To determine whether altered bone 
resorption was the cause of the bone phenotype in Ctnnb1f/f;CtsKCre mice, osteoclast numbers were evaluated in 
histological sections of femur and vertebra. Tartrate-resistant acid phosphatase (TRAP) specific staining revealed 
an increase in osteoclasts in the distal femur and lumbar vertebra of 4-week-old experimental mice as compared 
to littermate controls (Fig. 5a,b). Indeed, quantitation of osteoclasts in representative vertebral sections confirmed 
that osteoclast numbers were significantly increased in experimental mice (Fig. 5c) at 4 weeks of age just before 
the phenotype was apparent. However, and in line with the μ CT results, the bone area per total area did not show 
differences between control and experimental mice (Fig. 5d), confirming the late onset of the osteopenic pheno-
type. Osteoclasts were barely detectable in 12-week-old experimental animals, likely because a great portion of 
the cancellous bone was already lost (Fig. 5a,b). Overall, our results strongly suggest that an increase in osteoclast 
numbers is the primary cause of the bone defects in Ctnnb1f/f;CtsKCre mice.
Wnt/βcatenin signaling promotes osteoclast apoptosis and attenuates osteoclast numbers in 
vitro. We also assessed the number of osteoclast progenitors in the BM by culturing BM-cells obtained from the 
femur of control and experimental mice in the presence of RANKL and M-CSF for 5 days. The number of osteo-
clasts developed in cultures from Ctnnb1f/f;CtsKCre mice was significantly higher than in cultures from littermate 
controls (Fig. 5e). It should be noted that βcatenin deficient osteoclasts exhibited normal morphology indicating that 
βcatenin is dispensable for the intracellular cytoskeleton architecture and cell-cell adhesion of osteoclasts (Fig. 5e). 
As suggested in previous studies, plakoglobin may substitute for β catenin in these functions6,24,25.
In accordance with this observation, addition of recombinant WNT3A dose-dependently decreased the number 
of osteoclasts derived from BM of wild type mice in the presence of M-CSF and RANKL (Fig. 6a). Thus, stimulation 
of the canonical Wnt signaling attenuates the number of osteoclasts derived from BM cells in vitro. Because the genetic 
manipulation in our experimental mice occurs in a late phase of osteoclast differentiation, most likely when osteoclast 
are already postmitotic, we considered the alternative possibility of Wnt signaling modifying their life span.
Figure 2. X-ray and BMD analysis of Ctnnb1f/f;CtsKCre mice. (a) Radiographic imaging of the hindlimb and 
spine of experimental and control littermates at the stages indicated on the top. (b) Bone mineral density (BMD) 
(bone mineral content/total volume) of the femur and spine of control and experimental littermates at  
8 and 12 weeks of postnatal life. Bars, Mean ± SD; *P < 0.05.
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Figure 3. Micro–computed tomography analysis of Ctnnb1f/f;CtsKCre mice showing a severe loss of 
bone mass. (a) Representative μ CT images of the distal femur of the surface and mid-section of 6-week-old 
control and experimental littermates. (b) Histomorphometric quantification showing changes in trabecular 
number, trabecular space and trabecular thickness. (c) Representative μ CT images of the distal femur of 
the surface and mid-section of 12-week-old control and experimental littermates. (d) Histomorphometric 
quantification showing changes in bone volume, and trabecular thickness. BV/TV: bone volume fraction; 
Tb.N: trabecular number; Tb.Th: trabecular thickness; Tb.Sp: trabecular separation. Ct.Th: average cortical 
thickness. (e) Representative μ CT images of L5 vertebra of 12-week-old control and experimental littermates. 
(f) Histomorphometric quantification showing changes in experimental mice in all bone parameters analyzed. 
Surface and mid-sections are shown (indicated on the top). BV/TV: bone volume fraction; TbN: trabecular 
number; TbTh: trabecular thickness; TbSp: trabecular separation. CtTh: average cortical thickness. Bars, 
Mean ± SD; *P < 0.05
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Osteoclasts have a short life span and die by apoptosis, therefore, changes in their life span may alter osteoclast 
numbers. We next examined the role of Wnt/β catenin signaling in osteoclasts apoptosis. Addition of WNT3A 
to osteoclast cultures from BM of control littermates mice stimulated osteoclast apoptosis, as determined by 
the TUNEL assay (Fig. 6b). The pro-apoptotic effect of WNT3A was abrogated in osteoclast cultures obtained 
from Ctnnb1f/f;CtsKCre mice (Fig. 6b), confirming β catenin requirement for this effect. Addition of DKK1 to 
the cultures also blunted the pro-apoptotic actions of WNT3A in osteoclasts as determined by caspase 3 activity 
(Fig. 6c). These results show that canonical Wnt/β catenin signaling promotes osteoclast apoptosis in vitro.
Figure 4. Temporal histological analysis showing the late onset of the phenotype. (a) Sequential analysis 
of the distal femur shows normal bone development in experimental mice up to 4 weeks of postnatal life while 
wide areas of cortical bone loss (arrows) are observed in 12-week-old experimental animals. (b) Pictures of 
fresh dissected distal femur showing the dramatic bone loss of experimental animals. (c) The sequential analysis 
of lumbar vertebrae shows normal bone development in experimental mice up to 4 weeks with a dramatic bone 
loss phenotype observed in 12-week-old experimental animals. (d) Detail of the bone marrow of the 12-week-
old femurs in (A) showing the extensive adiposity characteristic of experimental animals. (e) Hematoxylin-
eosin stained histological sections of the proximal humerus of control and experimental. Scale bar, 1000 μ m.
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A decline in OPG in cells other than osteoclasts contributes to the low-bone-mass in Ctnnb1f/f; 
CtsKCre mice. The low-bone-mass phenotype in Ctnnb1f/f;CtsKCre mice is much more severe than that 
reported for Ctnnb1f/f/LysMCre mice15–17. Since the absence of βcatenin in osteoclasts is common to both 
Figure 5. Increased osteoclast numbers in experimental animals. (a,b) TRAP staining show excess osteoclasts 
(stained in red) in 4-week-old experimental animals. (c) Osteoclast numbers per mm bone surface in cancellous 
bone of L2-4 vertebra of 4-week-old control (n = 6) and experimental (n = 6) littermates and representative 
histological photomicrographs of vertebral trabecular bone. (d) Histomorphometric analysis of longitudinal 
decalcified sections of L2–L4 vertebrae from 4-week-old female mice (n = 6 mice per group) showing no difference 
in bone area per tissue area (BA/TA) between control and experimental animals. (e) Quantification of TRAP-
positive cells generated from bone marrow cells cultured with M-CSF and RANKL for 5 days and representative 
microphographs of the culture dishes. Bars, Mean ± SD; *P < 0.05. Scale bar, 1000 μ m.
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models, the discrepancy in the phenotype suggests the involvement of additional cell targets in one or both 
models. Indeed, several observations pointed to additional contribution of non-osteoclast cells to the pheno-
type of Ctnnb1f/f;CtsKCre mice. First, the similarity of the bone phenotype with that of mice in which βcatenin 
was removed from osteoblasts and osteocytes, or chondrocytes suggested a common causal mechanisms11,12,24,26. 
Second, the evaluation of βcatenin mRNA expression level in the experimental bone (assessed in tibia from 
4-week-old animals) was reduced by 70%, much more than expected if only osteoclasts, which represent only a 
scanty 3–5%, proportion of bone cells, were responsible for this decrease (Fig. 7a).
Since a decline in OPG is the main culprit for the increased resorption in mice in which βcatenin was deleted 
from osteoblast but not from osteoclast lineage cells, we measured Opg mRNA expression in the whole tibia 
in control and Ctnnb1f/f;CtsKCre mice. Opg mRNA levels were significantly decreased in experimental mice 
(Fig. 7b). In contrast, RANKL expression was indistinguishable from littermate controls (Fig. 7b). The decrease 
in OPG in Ctnnb1f/f;CtsKCre mutant mice provides an additional cause for the increase in osteoclast numbers and 
strongly suggests that CtsK-Cre targets cells other than osteoclasts.
To identify this putative cell type we analyzed the mRNA expression pattern of CtsK by in situ hybridiza-
tion in tissue sections of femur and vertebra from embryonic day (E) 13.5 to 4 weeks of postnatal development 
(Supplemental Fig. 1 and not shown). CtsK expression was first detected at E16.5 and, during this and subsequent 
developmental stages, the pattern of CtsK-expressing cells coincided with the distribution of TRAP positive cells, 
as expected (Fig. 7c and Supplemental Fig. 1).
Importantly, the expression of CtsK was also found in TRAP negative cells located in the inner layer of the 
periosteum (red arrows in Fig. 7c). The periosteum is a thick sheet that covers the outer surface of bones and is 
composed of two distinct layers: an outer fibrous layer that lends structural integrity and an inner layer that has 
osteogenic potential. The fibrous layer is primarily composed of fibroblasts, collagen, and elastin while the inner 
layer, also called the cambium layer, is highly cellular and includes differentiated osteogenic progenitors, adult 
mesenchymal progenitor cells and osteoblasts27–29.
The periosteal CtsK-expressing cells appeared scattered in the cambium layer, not in direct contact with the 
bone surface, but adjacent to the line of cuboid osteoblasts (Fig. 7c,d). At postnatal (P) day 7, these cells were 
negative for Collagen type1 (Col1), Bone sialoprotein (Bsp), and sclerostin (Sost) (Fig. 7c). Most interestingly, at 
P15, these cells also expressed Col1 but not Bsp or Sost, suggesting that they are a subpopulation of undifferenti-
ated osteogenic cells (Fig. 7d). It should be noted that we could not detect CtsK expression in osteocytes or in the 
Ranvier groove at this stage (Fig. 7). Together, these results strongly indicate that the CtsKCre line targets cells 
other than osteoclasts in bone and that deletion of βcatenin in these cells contributes to the loss of bone mass in 
Ctnnb1f/f;CtsKCre mice.
Discussion
The aim of this work was to examine the function of Wnt/β catenin signaling specifically in mature osteoclasts. 
Surprisingly, the removal of βcatenin at a late stage of osteoclast differentiation using the CtsKCre line caused a 
much more severe low-bone-mass phenotype than when βcatenin is removed from early myeloid precursors 
Figure 6. WNT3A induces osteoclast apoptosis via the canonical Wnt signaling pathway. (a) Number of 
TRAP-positive cells generated from non-adherent bone marrow cells from C57BL/6 control mice cultured 
with M-CSF, RANKL and either vehicle (veh) or different doses of WNT3A recombinant protein as indicated. 
(b) TUNEL assay in mature osteoclasts generated from bone marrow cells from Ctnnb1f/f;CtsKCre mice and 
their respective littermate controls, cultured with M-CSF and RANKL for 5 d and treated with either veh 
or WNT3A (50 ng/ml) for 24 h. (c) Caspase 3 activity, expressed in arbitrary fluorescent units, in mature 
osteoclasts generated from non-adherent bone marrow cells from wild-type mice, and treated with veh, 
WNT3A (50 ng/ml) or DKK1 (1 μ g/ml) for 24 h. Bars, Mean ± SD; *P < 0.05.
www.nature.com/scientificreports/
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Figure 7. Reduced βcatenin and Opg mRNA expression in experimental bone tissue and pattern of CtsK 
expression in bone. (a) Quantitative RT-PCR analysis of βcatenin mRNA from a battery of tissues harvested 
from 4-week-old mice (n = 3) showing specific but disproportionate reduction in bone. (b) Quantitative RT-
PCR of Opg and Rankl mRNA in tibia of control mice and their experimental littermates (n = 4). (c) TRAP and 
in situ hybridization for CtsK, Col1, Bsp and Sost in consecutive sections of the distal femur of a P7 wild type 
animal. The marked square in the top row (bar: 150 μ m) is amplified in the bottom row (bar: 30 μ m). Note the 
presence of CtsK expressing cells (red arrows) in the inner layer of the periosteum that however are negative 
for TRAP staining and other osteoblastic markers. (d) TRAP and in situ hybridization for CtsK and Col1 in 
consecutive sections of the distal femur of a P15 wild type animal. The marked square in the top row (bar: 50 μ m) is 
amplified in the bottom row (bar: 30 μ m). At this stage the CtsK positive cells of the cambium layer also express 
Col1. Bars, Mean ± SD; *P < 0.05.
www.nature.com/scientificreports/
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using the LysMCre line15–17. While Ctnnb1f/f;LysMCre mice show a mild reduction in the femur trabecular bone15, 
the Ctnnb1f/f;Ctsk-cre mutants show a dramatic loss of both trabecular and cortical bone in both long bones and 
vertebra. Because in both animal models the mature osteoclast is deficient in βcatenin, it is reasonable to assume 
that the discrepancies in the phenotype rely on additional targets, distinct from osteoclasts, present in one or 
both of these models. Also, it should be considered that Ctnnb1f/f;CtskCre mice lack a functional allele of Ctsk, 
one of the most potent collagenases30. This raises the question of whether the degradation of ECM proteins, such 
as collagen and elastin, could be impaired in our experimental mice and contribute to the phenotype. However, 
this possibility can be discarded because Ctsk heterozygous mutant have no bone phenotype31,32 and because the 
Ctnnb1f/f;CtskCre phenotype is characterized by excessive rather than limited osteoclasts function.
Here, we have focused on the causes of the severe low-bone-mass in Ctnnb1f/f;CtsKCre mice and show that it 
associates with excessive osteoclast numbers evident at the end of the first month of postnatal life and coincident 
with the onset of the phenotype. The increase in osteoclast numbers results from the combination of two mech-
anisms. First, the removal of βcatenin in mature osteoclasts extends their life span in a cell-autonomous manner 
and second, the additional activity of the CtsKCre line in a sub-population of osteoblasts leads to increased oste-
oclastogenesis through the reduction in OPG production.
An essential role for βcatenin in controlling osteoclastogenesis has been previously demonstrated. It has been 
shown that WNT3A reduces osteoclast numbers by sustaining M-CSF–induced proliferation of osteoclasts pre-
cursors and preventing their differentiation into mature osteoclasts15,17. Recently, it has been shown that WNT3A 
suppresses RANKL-mediated NFATc1 expression in osteoclast precursors, while activates the cAMP/PKA path-
way, as mechanisms by which WNT3A blunts osteoclast differentiation18.
Our in vitro experiments provide compelling evidence for a role of cell-autonomous Wnt/βcatenin signaling in 
reducing the life span of osteoclasts. The pro-apoptotic effect of Wnt/β catenin in osteoclasts may occur all along 
the osteoclast differentiation life as an additional mechanism together with the attenuation of differentiation, and 
our experiments suggest that this effect is still present at the end of the osteoclastic differentiation process. Several 
studies have demonstrated that modulation of osteoclasts life span leads to changes in bone mass33. For example, 
estrogens protect the skeleton, in part, via pro-apoptotic effects in osteoclasts21,34. Indeed, deletion of ERα in the 
osteoclast lineage cells, similar to deletion of βcatenin, increases osteoclast numbers and decreases bone mass. 
In contrast to estrogens, glucocorticoids cause loss of bone mass, at least in part, via prolongation of osteoclast 
life span. Interestingly, and similar to estrogens and glucocorticoids, Wnt/β catenin signaling exerts an opposite 
effect on the life span of osteoblasts and osteoclasts i.e. it increases the life span of osteoblasts and decreases the 
life span of osteoclasts35. Similar to our findings in osteoclasts, WNT3A/β catenin mediate the effects of hypoxia 
reoxygenation on rat cardiomyoblasts cell death36. Moreover, Wnt/β catenin signaling decreases melanoma cell 
invasiveness by a mechanism that enhances the expression of pro-apoptotic proteins37.
Several findings in Ctnnb1f/f;CtsKCre mice pointed to the involvement of cells other than osteoclasts in the 
bone phenotype of these mice. First, the reduction in the expression of βcatenin in bone is much higher than 
expected from the sole removal in osteoclasts, a minority cell type in bone. Second, the expression of Opg, a 
well-known target of βcatenin in osteoblasts, is dramatically reduced in bone. Third, the bone phenotype, includ-
ing the excessive bone marrow adipocytes, is reminiscent of the phenotype exhibited by mice in which βcatenin is 
deleted in osteoblasts, osteocytes or chondrocytes11,12,24,26,38. These observations, together with the identification 
in the inner periosteal layer of cells that are TRAP-negative but concomitantly express CtsK and Col1, support the 
conclusion that a sub-population of osteogenic cells contributes to the phenotype via indirect control of osteoclas-
togenesis. Because the CtsK-expressing cells identified here are located in the inner layer of the periosteum and 
express Col1 at P15, we propose that they are a sub-population of osteoblastic cells. Although it has been reported 
that osteocytes can express CtsK under certain circumstances39, our study failed to detect cells that concomitantly 
expressed Sost and CtsK during the period studied.
Besides Wnt/β catenin, Bmp signaling is another important pathway regulating both bone formation and bone 
resorption and it is known that both pathways interact in complex and varied ways2,40. Thus, Bmp signaling, 
through the Bmpr1a, positively regulates sclerostin expression as well as canonical Wnt signaling41,42. In addition, 
Wnt/β catenin signaling is required for the Bmp osteogenic effects43 and Bmp2 directly enhances osteoclastic dif-
ferentiation and survival by regulating expression of RANKL and CSF144,45. While less is known on Wnt/β catenin 
modulation of Bmp signaling in bone, recent studies have shown upregulation of Bmp ligands by Wnt/β catenin 
signaling46. Thus, it is possible that Bmp signaling is altered in Ctnnb1f/f;CtsKCre mice, an issue that certainly 
deserves further analysis.
Interestingly, CtsK expression has also been recently described surrounding the physis, in the anatomical 
structure called the groove of Ranvier, which contains osteochondro-progenitor cells that contribute to bone 
development47. However, despite careful analysis we could not detect CtsK expressing cells in such location, rul-
ing out the participation of this structure in the phenotype of our experimental mice.
Methods
Mutant mice. The βcatenin floxed allele (Ctnnb1f)23 was obtained from Jackson Laboratory (Bar Harbor, 
Maine) and the CtsKcre line21 was provided by Dr. Shigeaki Kato (Institute of Molecular and Cellular Biosciences, 
University of Tokyo). Mice were genotyped by PCR following standard procedures. All animal procedures were 
conducted accordingly to the EU regulations and 3R principles and reviewed and approved by the Bioethics 
Committee of the University of Cantabria. A total of 13 males and 17 females of experimental mice and 21 males 
and 20 females for control animals were used.
DEXA bone mineral density. Bone mineral density (BMD) measurements were performed in 10 animals 
per genotype by DEXA using a PIXImus-II densitometer (GE Healthcare Lunar, Piscataway, NJ). Total spine and 
right femur BMD measurements were performed according to the manufacturer.
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Micro-computer tomography (μCT). μ CT analysis of the fifth lumbar vertebra and right femur of 10 
mice per genotype was performed into 12.3 mm diameter scanning tubes and imaged (μ CT40, Scanco Medical, 
Basserdorf, Switzerland). Scans were integrated into 3-D voxel images (1024 × 1024 pixel matrices for each indi-
vidual planar stack) and a Gaussian filter (sigma = 0.8, support = 1) was used to reduce signal noise. A threshold 
of 200 was applied to all analyzed scans. Scans were done at medium resolution (E = 55 kVp, I = 145 μ A, integra-
tion time = 200ms). The entire vertebral body was scanned with a transverse orientation excluding the pedicles 
and articular processes. Manual analysis excluded the cortical bone and the primary spongiosa from the analysis. 
All trabecular measurements were made by manually drawing contours every 10 to 20 slices and using voxel 
counting for bone volume per tissue volume and sphere filling distance transformation indices without assump-
tions about the bone shape as a rod or plate for trabecular microarchitecture. Cortical thickness was measured at 
the femur mid-diaphysis. Densitometry, and μ CT analyses were performed blind.
Bone histology. Three lumbar vertebrae (L2-4) and left femur of 6 animals for each genotype, were fixed in 
4% paraformaldehyde overnight at 4 °C and decalcified in 9% EDTA (pH7.4) for a variable time period, depend-
ing on the stage, before embedding in paraffin. For the histomorphometric analysis, osteoclasts were stained for 
tartrate-resistant acid phosphatase (TRAP) and measurements performed with Fiji software. Data are reported 
using the nomenclature recommended by the American Society for Bone and Mineral Research.
Cell culture. To quantify osteoclast progenitor cells, bone marrow (BM) was flushed out from long bones of 3 
mice for each genotype and plated in triplicates at a density of 50,000 cells/cm2 in 48 well plates. After 4–5 days of 
culture in α -MEM medium (Invitrogen), supplemented with 10% FBS, 1% PSG, 30 ng/ml M-CSF, and 30 ng/ml 
sRANKL (R&D Systems) the cells in the plate were fixed with 10% neutral buffered formaldehyde for 15 min and 
osteoclasts detected by staining for TRAP. Non adherent BM cells depleted of stromal cells were used for the rest 
of culture experiments.
Quantitative real-time PCR (qRT-PCR). Total RNA of 4 animals per genotype, was extracted with 
TRIzol reagents (Life Tecnologies). 1μ g total RNA was used to produce first-strand cDNA using the m-MLV 
RT enzyme (Invitrogen). qRT-PCR was carried out in duplicates using the PreMix Ex taq (Takara) and the data 
were analyzed using the Biorad software. The primers and probes for βcatenin [Mm01350385_g1 (fam)], and 
gapdh [Mm99999915_g1 (vic)] were manufactured by the TaqMan Gene. Expression Assays service (Applied 
Biosystems).
RT-PCR for Rankl and Opg expression was analyzed in a termocycler (Step One Plus Real Time PCR 
Systems, Applied Biosystems) using the SYBRGreen PCR Master Mix (Invitrogen). The primers used were: 
Rankl (F: 5′ -AAATTAGCATTCAGGTGTCC-3′ and R: 5′ -AATGTTCCACGAAATGAGTC-3′ ) and Opg  
(F: 5′ -AAAAATGTCCAGATGGGTTC-3′ and R: 5′ -ACACAGGGTGACATCTATTC-3′ ). The relative expression 
of mRNA obtained was normalized to tubulin, used as housekeeping (F: 5′ -GCAGTGCGGCAACCAGAT-3′ and 
R: 5′ -AGTGGGATCAATGCATGCT-3′ ). Relative mRNA expression levels were normalized to the mentioned 
housekeeping using the Δ Ct method48.
Apoptosis assays. Osteoclasts derived from purified non-adherent bone marrow osteoclast precursors iso-
lated from 3 animals for each genotype were treated with WNT3A once osteoclasts had developed in the culture 
plate in triplicates. After 24 hours of treatment, the cultures were fixed and subject to TUNEL and TRAP staining. 
The total number of osteoclasts and the number of apoptotic osteoclasts in the plate were quantified. Osteoclasts 
were considered apoptotic when at least one of their nuclei was TUNEL positive. The TUNEL method was per-
formed using the FragEL DNA fragmentation detection kit (EMD Chemicals, San Diego, CA) before staining 
for TRAP. Multinuclear TRAP-positive and TUNEL-positive cells were enumerated. Caspase-3 activity was 
measured by determining the degradation of the fluorometric substrate DEVD (Biomol Research Laboratories, 
Plymouth Meeting, PA), and protein concentration was measured using a Bio-Rad detergent-compatible kit 
(Bio-Rad Laboratories, Hercules, CA).
In Situ Hybridization. In situ hybridization was performed in sections using digoxigenin-labeled antisense 
riboprobes. The probes used were Col1, Bsp and Sost8. A specific antisense RNA probe for CtsK was generated 
using the following primers: CtsK-F: gaccactgccttccaatacg and CtsK-R:ctgctggaggactccaatgt. A minimum of three 
mice of each stage were analyzed.
Statistical analysis. All data are reported as the mean ± standard deviation. Group mean values were com-
pared by Student’s unpaired two-tailed t test.
Reagents. WNT3A, Dickkopf-related protein 1 (DKK1), macrophage colony-stimulating factor (M-CSF), 
and soluble Receptor activator of nuclear factor kappa-B ligand (sRANKL) recombinant proteins were purchased 
from R&D Systems (Minneapolis, MN).
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